Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

2001 • 6,888 citations

Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

2000 • 2,694 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

2008 • 2,239 citations

IMMUNOLOGY OF MULTIPLE SCLEROSIS

2005 • 2,099 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

1994 • 1,932 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 1,908 citations

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

1995 • 1,903 citations

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

2006 • 1,601 citations

Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis

2004 • 1,146 citations

The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration

2006 • 750 citations

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

2007 • 690 citations

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

1999 • 653 citations

Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis

2007 • 616 citations

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

2006 • 434 citations

B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation

2006 • 303 citations

Autoimmune inflammation from the Th17 perspective

2006 • 289 citations

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

1997 • 249 citations

B cells and antibodies in CNS demyelinating disease

2001 • 246 citations

Regulatory Roles for Cytokine- Producing B Cells in Infection and Autoimmune Disease

2004 • 181 citations

The Immunology of Multiple Sclerosis

2008 • 155 citations

The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)

2005 • 92 citations

Roles of immunoglobulins and B cells in multiple sclerosis: From pathogenesis to treatment

2006 • 82 citations

B-cell differentiation in the CNS of patients with multiple sclerosis

2005 • 64 citations

B-cells in multiple sclerosis.

2006 • 48 citations